))
Untapped Government Policy Options for Getting Cheaper Generics to Market with Dr. Michael J. Birrer
Manage episode 386558211 series 3299436
Content provided by Paul Woodhull and The Capitol Forum. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Paul Woodhull and The Capitol Forum or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Dr. Michael J. Birrer, an expert in oncology, discusses the complexities of generic oncology drug shortages, exploring the root causes and potential solutions to this recurring problem. Dr. Birrer shares his perspectives on the impact of reimbursement policies, the role of government intervention, and the need for a more streamlined FDA process. The discussion also touches on the influence of insurance companies, the quality of medical expertise in insurance decisions, and the broader landscape of oncology drug development.
68 episodes
Share
